Squarepoint’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.33M Buy
4,382
+2,734
+166% +$827K ﹤0.01% 1366
2025
Q1
$546K Buy
1,648
+100
+6% +$33.1K ﹤0.01% 1856
2024
Q4
$478K Buy
+1,548
New +$478K ﹤0.01% 1956
2024
Q3
Sell
-5,170
Closed -$1.45M 2830
2024
Q2
$1.45M Buy
+5,170
New +$1.45M ﹤0.01% 1204
2024
Q1
Hold
0
2720
2023
Q1
Sell
-2,932
Closed -$851K 2559
2022
Q4
$851K Buy
+2,932
New +$851K ﹤0.01% 1181
2022
Q3
Sell
-4,074
Closed -$292K 2325
2022
Q2
$292K Buy
+4,074
New +$292K ﹤0.01% 1591
2022
Q1
Sell
-22,827
Closed -$1.93M 2591
2021
Q4
$1.93M Sell
22,827
-12,288
-35% -$1.04M 0.01% 888
2021
Q3
$2.8M Buy
35,115
+2,528
+8% +$202K 0.01% 660
2021
Q2
$3.17M Buy
32,587
+13,123
+67% +$1.28M 0.01% 621
2021
Q1
$2.28M Buy
19,464
+16,352
+525% +$1.91M 0.01% 682
2020
Q4
$346K Sell
3,112
-1,641
-35% -$182K ﹤0.01% 1765
2020
Q3
$564K Buy
4,753
+1,763
+59% +$209K 0.01% 1273
2020
Q2
$339K Buy
+2,990
New +$339K 0.01% 1500
2020
Q1
Sell
-21,301
Closed -$1.94M 2212
2019
Q4
$1.94M Buy
21,301
+17,409
+447% +$1.59M 0.01% 906
2019
Q3
$336K Buy
+3,892
New +$336K ﹤0.01% 1762
2019
Q2
Sell
-2,300
Closed -$288K 2471
2019
Q1
$288K Sell
2,300
-172
-7% -$21.5K ﹤0.01% 1748
2018
Q4
$279K Sell
2,472
-1,579
-39% -$178K ﹤0.01% 1522
2018
Q3
$867K Buy
4,051
+2,451
+153% +$525K 0.01% 1056
2018
Q2
$448K Sell
1,600
-2,192
-58% -$614K 0.01% 1225
2018
Q1
$443K Sell
3,792
-133
-3% -$15.5K 0.01% 1129
2017
Q4
$360K Buy
+3,925
New +$360K 0.01% 1381
2016
Q3
Sell
-1,551
Closed -$14K 1157
2016
Q2
$14K Buy
+1,551
New +$14K ﹤0.01% 1058
2016
Q1
Sell
-1,623
Closed -$20K 1331
2015
Q4
$20K Buy
+1,623
New +$20K ﹤0.01% 1207